FLORHAM PARK, NJ — November is both National Alzheimer's Disease Awareness Month and National Family Caregivers Month, and although the Alzheimer’s Association of Greater New Jersey's Walk to End Alzheimer’s events have already taken place for this season, there are still “More Than One Million Reasons to Hope” for a world without Alzheimer's.

Funds raised through the Walk to End Alzheimer’s, the world’s largest event to raise awareness and funds for Alzheimer’s care, support and research programs, not only fund care, support and educational programs throughout New Jersey, but they also help support research and development of new therapies and drugs to treat and ultimately cure Alzheimer's disease.

The Alzheimer’s Association of Greater New Jersey (AAGNJ) recently hosted five successful events, but fundraising continues through Dec. 31 because those involved want to ensure that “no stone is left unturned.”

Sign Up for Livingston Newsletter
Our newsletter delivers the local news that you can trust.

The association’s efforts to meet its fundraising goal were recently enhanced by exciting news that has surfaced about a drug in Phase 3 clinical trials that delays the progression of early-onset dementia. According to the AAGNJ, the trial drug will be submitted to the FDA for approval in early 2020.

“I am one of the recipients this Phase 3 clinical trial drug,” said Jeff Borghoff, a 55-year-old advocate living with Alzheimer’s disease. “This drug will slow the progression of the disease, and it is important to know that your fundraising dollars have helped to make this a reality. It has helped to make it a reality in my life.”

Borghoff recently shared his belief that “hope requires action” in the way of commitment, advocacy, education, support and fundraising through a video explaining how community members can help turn hope into action.

“This new development is proof that your support fuels this fight, and makes a difference for the millions living with Alzheimer's and their families,” said Cheryl Ricci-Francione, executive director of AAGNJ.

More than 5 million Americans are currently living with Alzheimer's disease, which is the sixth-leading cause of death in the United States and the only disease among the top 10 causes that cannot be cured, prevented or even slowed.

According to Ricci-Francione, the Alzheimer’s Association, which is the world’s largest nonprofit funder of Alzheimer’s and dementia research, has been involved with every major advancement in Alzheimer’s and dementia research since the 1980s.

“At the Alzheimer’s Association, we have more than a million reasons to hope, and we hope for the first survivor,” Borghoff said in his video. “With your support, the Alzheimer’s Association unites the scientific community, academic researchers, government and industry leaders worldwide to accelerate research.

“Fundraising to meet our goal continues through the end of December. Please help us leave no stone unturned. Go to the link below and donate.”

As part of its “More Than One Million Reasons to Hope” campaign, the Alzheimer’s Association is encouraging community members to help in this fight by donating to their local Walk to End Alzheimer’s.

CLICK HERE NOW to contribute to the Essex/Hudson/Union Walk to End Alzheimer’s.